nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo searchdiv qikanlogo popupnotification paper paperNew
2025, 14, v.66 1424-1427+1432
仝小林运用开郁降浊法论治糖尿病前期合并超重或肥胖经验
基金项目(Foundation): 国家自然科学基金(82274343); 中国中医科学院广安门医院临床医学研究中心建设专项(2022LYJSZX25)
邮箱(Email): melonzhao@163.com;
DOI: 10.13288/j.11-2166/r.2025.14.003
摘要:

总结仝小林教授运用开郁降浊法论治糖尿病前期合并超重或肥胖的临床经验。认为糖尿病前期属于中医学“脾瘅”范畴,其核心病机为中满内热,而肥胖则是加剧中满内热的始动因素,故截断超重、肥胖与糖代谢异常之间的转化对降低糖尿病发病风险具有重要意义。提出糖尿病前期合并超重或肥胖的主要病机为中焦气郁浊阻,以气郁为本、浊阻为因,形成了以开郁降浊法为核心的治疗思路。临床采用大黄黄连泻心汤为基础方,以泄浊为主、辅以行气,取寓行于降之意,澄脾瘅之源,并结合患者证候虚实灵活加减,实现个体化诊疗。

Abstract:

This article summarised the clinical experience of Professor TONG Xiaolin in treating prediabetes combined with overweight or obesity using the method of relieving depression and reducing turbidity. It is believed that prediabetes belongs to the category of "spleen-heat syndrome" in traditional Chinese medicine, and its core pathogene-sis is fullness in center with internal heat, while obesity is the initiating factor for exacerbating center fullness and internal heat. Therefore, it is of great significance to reduce the risk of diabetes by interrupting the transformation between overweight, obesity and glucose metabolism abnormality. It is proposed that the main pathogenesis of predia-betes combined with overweight or obesity is qi depression and turbidity obstruction in middle jiao, with qi depression as the root and turbidity obstruction as the cause, forming a treatment idea with the method of relieving depression and reducing turbidity as the core. In clinic, Dahuang Huanglian Xiexin Decoction (大黄黄连泻心汤) is used as the basic prescription, with a primary focus on directing the turbid downward, supplemented by regulating qi, which embodies the concept of "promoting movement through descent, then figuring out the root of spleen-heat syndrome. Furthermore, the treatment is flexibly modified based on the patient's deficiency-excess syndrome to ensure individualized therapy.

参考文献

[1]DENG W,ZHAO L,CHEN C,et al.National burden and risk factors of diabetes mellitus in China from 1990 to2021:results from the Global Burden of Disease study2021[J].J Diabetes,2024,16(10):e70012.

[2]中华医学会内分泌学分会,中华医学会糖尿病学分会,中国医师协会内分泌代谢科医师分会.中国成人糖尿病前期干预的专家共识(2023版)[J].中华糖尿病杂志,2023,15(6):484-494.

[3]邸莎,杨映映,赵林华,等.从“火”论治糖尿病[J].中国中医基础医学杂志,2020,26(12):1765-1768.

[4]仝小林,姬航宇,李敏,等.脾瘅新论[J].中华中医药杂志,2009,24(8):988-991.

[5]仝小林,刘文科,王佳,等.糖尿病郁热虚损不同阶段辨治要点及实践应用[J].吉林中医药,2012,32(5):442-444.

[6]YU HJ,HO M,LIU X,et al.Association of weight status and the risks of diabetes in adults:a systematic review and metaanalysis of prospective cohort studies[J].Int J Obes(Lond),2022,46(6):11011113.

[7]US Preventive Services Task Force.Screening for prediabetes and type 2 diabetes:US Preventive Services Task Force Recommendation Statement[J].JAMA,2021,326(8):736-743.

[8]SZUKIEWICZ D.Molecular mechanisms for the vicious cycle between insulin resistance and the inflammatory response in obesity[J].Int J Mol Sci,2023,24(12):9818.

[9]方朝晖,仝小林,段俊国,等.糖尿病前期中医药循证临床实践指南[J].中医杂志,2017,58(3):268-272.

[10]李洪皎,仝小林,吴洁,等.肥胖2型糖尿病前期、早期病机证治探讨[J].中国中医基础医学杂志,2007,13(7):529-530.

[11]魏军平,刘芳,周丽波,等.北京市糖耐量异常和糖尿病危险因素及中医证候流行病学调查[J].北京中医药,2010,29(10):731-737.

[12]仝小林.论辨症、辨病、审因与辨证论治在临床中的应用[J].中医杂志,2013,54(2):93-95.

[13]逄冰,刘文科,郑玉娇,等.仝小林从“六郁”谈糖尿病前期的中医证治[J].北京中医药,2017,36(6):505-507.

[14]王佳,冯磊,仝小林.仝小林教授运用黄连不同配伍经验[J].中医药导报,2015,21(22):16-20.

[15]林潼,张湘苑,沈梦菲,等.重构本草:大黄[J].吉林中医药,2023,43(2):215-217.

[16]张伟,康梦娇,苟筱雯,等.重构本草:黄连[J].吉林中医药,2024,44(4):467-470.

[17]王翼天,仝小林.分类、分期、分证思想对慢性病中医理论构建的启示[J].中医杂志,2017,58(24):2091-2094.

[18]温志歌,黄一珊,杨映映,等.仝小林从“土壅”论治肥胖[J].中医杂志,2022,63(10):914-917.

基本信息:

DOI:10.13288/j.11-2166/r.2025.14.003

中图分类号:R249;R259

引用信息:

[1]王思成,刘扬扬,燕艳等.仝小林运用开郁降浊法论治糖尿病前期合并超重或肥胖经验[J].中医杂志,2025,66(14):1424-1427+1432.DOI:10.13288/j.11-2166/r.2025.14.003.

基金信息:

国家自然科学基金(82274343); 中国中医科学院广安门医院临床医学研究中心建设专项(2022LYJSZX25)

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文